Development of high throughput sequencing techniques allowed us to assess multiple MS-patient CSF IGHV-repertoires (33), and advances in epitope prediction models including protease cleavage probabilities allowed identification of multiple idiotopes potentially capable of HLA-DR presentation as well as release by cathepsin cleavage (9). This evidence concerns the gene CTSS and myeloid sarcoma.